Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Drospirenone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing drospirenone and ethinylestradiol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Drospirenone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely drospirenone 2 milligram and estradiol 1 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Drospirenone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing drospirenone and estradiol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Drospirenone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely drospirenone 500 microgram and estradiol 1 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Drospirenone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing drospirenone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Drospirenone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Drospirenone 3 mg and ethinylestradiol 20 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Drospirenone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Drospirenone 3 mg and ethinylestradiol 20 microgram and levomefolate calcium 451 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Drospirenone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Drospirenone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Drospirenone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely drospirenone 500 microgram and estradiol 1 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Drospirenone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Drospirenone 3 mg and ethinylestradiol 20 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Drospirenone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Drospirenone 3 mg and ethinylestradiol 20 microgram oral tablet |
Has basis of strength substance (attribute) |
False |
Drospirenone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Drospirenone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely drospirenone 2 milligram and estradiol 1 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Drospirenone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely drospirenone 2 milligram and estradiol 1 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Drospirenone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely drospirenone 500 microgram and estradiol 1 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Drospirenone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely drospirenone 500 microgram and estradiol 1 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Drospirenone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only ethinylestradiol 0.03 milligram and drospirenone 3 milligram/1 each oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Drospirenone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only ethinylestradiol 0.03 milligram and drospirenone 3 milligram/1 each oral tablet |
Has basis of strength substance (attribute) |
False |
Drospirenone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Drospirenone 3 mg and ethinylestradiol 20 microgram oral tablet |
Has precise active ingredient |
False |
Drospirenone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing drospirenone and estradiol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Drospirenone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing drospirenone and ethinylestradiol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Drospirenone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely drospirenone 2 milligram and estradiol 1 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Drospirenone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
False |
Drospirenone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely drospirenone 500 microgram and estradiol 1 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
False |
Drospirenone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Drospirenone only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Drospirenone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only drospirenone and estradiol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Drospirenone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Drospirenone and ethinylestradiol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Drospirenone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Drospirenone and estradiol only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Drospirenone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only drospirenone and ethinylestradiol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Drospirenone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only drospirenone and ethinylestradiol and levomefolic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Drospirenone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Drospirenone- and ethinylestradiol- and levomefolic acid-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Drospirenone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Drospirenone 3 mg and ethinylestradiol 20 microgram and levomefolate calcium 451 microgram oral tablet |
Has precise active ingredient |
True |
Drospirenone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Drospirenone 3 mg and ethinylestradiol 20 microgram and levomefolate calcium 451 microgram oral tablet |
Has basis of strength substance (attribute) |
True |
Drospirenone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only drospirenone and ethinylestradiol and levomefolic acid in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Drospirenone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Drospirenone- and ethinylestradiol- and levomefolic acid-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Drospirenone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Drospirenone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely drospirenone 500 microgram and estradiol 1 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Drospirenone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Drospirenone 3 mg and ethinylestradiol 20 microgram oral tablet |
Has basis of strength substance (attribute) |
True |
Drospirenone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Drospirenone 3 mg and ethinylestradiol 20 microgram oral tablet |
Has precise active ingredient |
True |
Drospirenone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely drospirenone 3 milligram and estetrol 14.2 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Drospirenone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely drospirenone 3 milligram and estetrol 14.2 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Drospirenone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Drospirenone- and estetrol-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Drospirenone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only drospirenone and estetrol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Drospirenone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Drospirenone- and estetrol-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Drospirenone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Drospirenone and estetrol only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Drospirenone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Drospirenone 3 mg and ethinylestradiol (as ethinylestradiol betadex clathrate) 20 microgram oral tablet |
Has precise active ingredient |
True |
Drospirenone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Drospirenone 3 mg and ethinylestradiol (as ethinylestradiol betadex clathrate) 20 microgram oral tablet |
Has basis of strength substance (attribute) |
True |
Drospirenone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |